At the news
? NEUTRALIMPACT 3/10 6-K filed May 6, 2026 at 16:28 ET
argenx announced results of its Annual General Meeting and the appointment of Karen Massey as CEO, succeeding founder Tim Van Hauwermeiren who becomes Chair. Shareholders approved all agenda items, including a 10% share issuance authorization. The leadership transition is orderly and the founder remains involved, limiting disruption risk.
- Karen Massey appointed CEO effective immediately, succeeding founder Tim Van Hauwermeiren.
- Tim Van Hauwermeiren appointed Chairperson of the Board.
- All agenda items approved at AGM, including 2025 remuneration report and annual accounts.
- Authorization to issue up to 10% of outstanding shares for 18 months, with pre-emptive rights exclusion possible.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access